307.49USD-2.06%Mkt Cap: 8.22B USDP/E: 51.21Last update: 2026-06-01
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap8.22B USD
Enterprise Value8.18B USD
Revenue (TTM)2.59B USD
Gross Profit1.34B USD
Net Income (TTM)759.90M USD
Revenue/Share95.80 USD
Last Price307.49 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS0905722072
Valuation
P/E (Trailing)51.21
P/E (Forward)32.14
PEG4.01
EV/EBITDA18.38
EV/Revenue3.16
P/S3.23
P/B1.22
EPS (TTM)6.01
EPS (Forward)9.72
52W Range
211.4373% of range343.12
52W High343.12 USD
52W Low211.43 USD
Profitability
Gross Margin51.87%
Oper. Margin5.76%
EBITDA Margin17.17%
Profit Margin29.42%
ROE10.20%
ROA7.18%
Growth
Revenue Growth1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF532.20M USD
CapEx (TTM)157.60M USD
FCF Margin8.87%
FCF Yield2.79%
Net Debt-186.50M USD
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity0.19
Current Ratio3.21
Quick Ratio2.19
Book Value/Sh255.37 USD
Cash/Share58.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)297.00 USD
Target Range275.00 USD – 320.00 USD
# Analysts5
Ownership
Shares Out.21.70M
Float20.90M
Insiders16.38%
Institutions94.42%
Short Interest
Short Ratio0.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short46
Short (prev mo.)29
Technical
SMA 50277.50 (+10.8%)
SMA 200293.50 (+4.8%)
Beta1.06
S&P 52W Chg27.70%
Avg Vol (30d)402.96K
Avg Vol (10d)557.46K
Technical Indicators
RSI (14)69.6
MACD9.0529
MACD Signal2.2749
MACD Hist.+6.7781
BB Upper320.11 USD
BB Middle271.01 USD
BB Lower221.91 USD
BB Width36.24%
ATR (14)11.15 USD
Vol Ratio (20d)0.54x